A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

NCT01692145 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: KCT-0809
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.